Collaboration in groups during teacher education

Collaboration is increasingly common among teachers in schools. As such, teacher education should prepare prospective teachers to effectively interact with other teachers in different types of communities or groups. This dissertation sheds light on the way student teachers are prepared to collaborate while taking part in different types of groups (mentor group, subject matter group, reflection group and research group) in teacher education. The findings and recommendations provide guidance about how to improve prospective teachers' collaborative abilities.UBL - phd migration 201

Transparency and (no) more in the Political Advertising Regulation

The EU has taken its first steps into a sensitive space by proposing a new Regulation on Political Advertising (RPA). Simply put, the RPA does two things, which this commentary will address in turn. First, it replaces national laws on the transparency of political advertising with a single set of rules. These provide progressively more information to citizens who see an ad, to the public through ad libraries, and to regulators and private actors who are authorised to request information. Second, the RPA tightens the GDPR’s ban on using sensitive data for targeted political advertising. It leaves member states free, however, to further regulate the use of political advertising.The RPA takes a number of important steps in political advertising law. It strengthens the transparency of the (so far largely unregulated) online political advertising environment. It expands ad libraries with information on targeting and funding. And it allows a broad range of private actors (including civil society and journalists) to request data from a broad range of companies (including ad agencies and small platforms). At the same time, the RPA not only represents the EU’s most significant effort to address concerns about political advertising’s democratic impact, but (because it fully harmonises transparency) also shapes how individuals, researchers, and national regulators can scrutinise political advertising. It is therefore important to determine whether the regulation lives up to the Commission’s hype

TeV Gamma-ray Observations of the Crab and Mkn 501 during Moonshine and Twilight

TeV Gamma-ray signals from the Crab Nebula and Mkn 501 were detected with the HEGRA CT1 imaging Cerenkov telescope during periods when the moon was shining and during twilight. This was accomplished by lowering the high voltage supply of the photomutipliers in fixed steps up to 13%. No other adjustments were made and no filters were used. Laser runs could not establish any non-linearity in the gain of the individual pixels, and the trigger rate was uniform over the whole camera. The energy threshol was increased by up to a factor of two, depending on the amount of HV reduction. In a series of observations lasting 11.7 hours, a signal with a 3.4 sigma significance was detected from the Crab. During the 1997 multiple flare episode of Mkn 501 a 26 sigma combined excess has been recorded during 134 hours of observations under various moonshine/twilight conditions. The results show that this technique can easily be adapted to increase the exposure of a source, which is important for sources showing rapid time variability such as AGNs or GRBs. Observations can be made up to ~20 deg. angular separation from the moon and until the moon is 85% illuminated (ten to eleven days before and after new moon), as well as during 20 to 40 minutes during twilight, before the commencement of astronomical darkness.Comment: 16 pages, 5 figures, submitted to Astroparticle Physic

Neonatal Colonisation Expands a Specific Intestinal Antigen-Presenting Cell Subset Prior to CD4 T-Cell Expansion, without Altering T-Cell Repertoire

Interactions between the early-life colonising intestinal microbiota and the developing immune system are critical in determining the nature of immune responses in later life. Studies in neonatal animals in which this interaction can be examined are central to understanding the mechanisms by which the microbiota impacts on immune development and to developing therapies based on manipulation of the microbiome. The inbred piglet model represents a system that is comparable to human neonates and allows for control of the impact of maternal factors. Here we show that colonisation with a defined microbiota produces expansion of mucosal plasma cells and of T-lymphocytes without altering the repertoire of alpha beta T-cells in the intestine. Importantly, this is preceded by microbially-induced expansion of a signal regulatory protein α-positive (SIRPα+) antigen-presenting cell subset, whilst SIRPα−CD11R1+ antigen-presenting cells (APCs) are unaffected by colonisation. The central role of intestinal APCs in the induction and maintenance of mucosal immunity implicates SIRPα+ antigen-presenting cells as orchestrators of early-life mucosal immune development

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study

Despite recent identification of several prognostic markers, there is still a need for new prognostic parameters able to predict clinical outcome in chronic lymphocytic leukemia (CLL) patients. Here, we aimed to validate the prognostic ability of known (proteomic) markers measured pretreatment and to search for new proteomic markers that might be related to treatment response in CLL. To this end, baseline serum samples of 51 CLL patients treated with chemo-immunotherapy were analyzed for 360 proteomic markers, using Olink technology. Median event-free survival (EFS) was 23 months (range: 1.25–60.9). Patients with high levels of sCD23 (>11.27, p = 0.026), sCD27 (>11.03, p = 0.04), SPINT1 (>1.6, p = 0.001), and LY9 (>8.22, p = 0.0003) had a shorter EFS than those with marker levels below the median. The effect of sCD23 on EFS differed between immunoglobulin heavy chain variable gene-mutated and unmutated patients, with the shortest EFS for unmutated CLL patients with sCD23 levels above the median. Taken together, our results validate the prognostic impact of sCD23 and highlight SPINT1 and LY9 as possible promising markers for treatment response in CLL patients

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

Lenalidomide has been proven to be effective but with a distinct and difficult to manage toxicity profile in the context of chronic lymphocytic leukemia, potentially hampering combination treatment with this drug. We conducted a phase 1-2 study to evaluate the efficacy and safety of six cycles of chlorambucil (7 mg/m2 daily), rituximab (375 mg/m2 cycle 1 and 500 mg/m2 cycles 2-6) and individually-dosed lenalidomide (escalated from 2.5 mg to 10 mg) (induction-I) in first-line treatment of patients with chronic lymphocytic leukemia unfit for treatment with fludarabine, cyclophosphamide and rituximab. This was followed by 6 months of 10 mg lenalidomide monotherapy (induction-II). Of 53 evaluable patients in phase 2 of the study, 47 (89%) completed induction-I and 36 (68%) completed induction-II. In an intention-to-treat analysis, the overall response rate was 83%. The median progression-free survival was 49 months, after a median follow-up time of 27 months. The 2- and 3-year progression-free survival rates were 58% and 54%, respectively. The corresponding rates for overall survival were 98% and 95%. No tumor lysis syndrome was observed, while tumor flair reaction occurred in five patients (9%, 1 grade 3). The most common hematologic toxicity was grade 3-4 neutropenia, which occurred in 73% of the patients. In conclusion, addition of lenalidomide to a chemotherapy backbone followed by a fixed duration of lenalidomide monotherapy resulted in high remission rates and progression-free survival rates, which seem comparable to those observed with novel drug combinations including novel CD20 monoclonal antibodies or kinase inhibitors. Although lenalidomide-specific toxicity remains a concern, an individualized dose-escalation schedule is feasible and results in an acceptable toxicity profile. EuraCT number: 2010-022294-34

Hegemon : tracing power through bodies of law

\u27I once had a conversation with a high-ranking member of the CPUSA ... who said that gay people should stay in the closet because it sets a bad example for the \u27working class\u27. \u27 US gay activist, in conversation: \u27The NSW-based Gay and Lesbian Rights Lobby recently knocked back a push by bisexuals and transsexuals to be accepted as part of its overall charter for lobbying ... Those who resisted most strongly were AIDS Council of NSW (ACON) president Peter Grogan, former Mardi Gras president Richard Cobden, gay NSW parliamentary member Paul O\u27Grady and interim head of the Australian Council for Lesbian and Gay Rights, Carole Ruthchild ... Those against the inclusion ... said that bisexuals could have lovers of the same sex but still resort to the \u27safety\u27 net of a heterosexual lifestyle ... The Gay and Lesbian Rights Lobby had earlier expelled Norrie May Welby under the premise that May Welby\u27s constant \u27queer\u27 arguments in committee meetings had delayed work on important rights issues.\u27 Campaign 207/June \u279